Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy

PHASE4TerminatedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Analgesic Adverse Reaction
Interventions
DRUG

Ketorolac Tromethamine

Ketorolac Tromethamine 0.5 mg/kg IV up to a maximum dose of 30mg, in the form of Ketorolac Tromethamine solution for IV/IM use 30mg/ml single dose vial at the completion of the tonsillectomy in the operating room.

DRUG

0.9% Normal Saline

0.9 % Normal saline 1ml/60kg up to a maximum dose of 1ml IV bolus (an equivalent volume as per kg Ketorolac Trimethamine dose) at the completion of the tonsillectomy in the operating room.

Trial Locations (1)

12208

Albany Medical Center, Albany

Sponsors
All Listed Sponsors
lead

Albany Medical College

OTHER